Cancer Risk Prediction & Assessment

Accurately assessing cancer risk in average- and high-risk individuals and determining cancer prognosis in patients are crucial to controlling the suffering and death due to cancer. Cancer prediction models provide an important approach to assessing risk and prognosis by identifying individuals at high risk, facilitating the design and planning of clinical cancer trials, fostering the development of benefit-risk indices, and enabling estimates of the population burden and cost of cancer. Models also may aid in the evaluation of treatments and interventions.

RFMMB staff, in collaboration with other NCI staff, have pursued this area of research through a number of avenues.